Passage BIO (PASG) Other Working Capital Changes (2024 - 2025)
Passage BIO (PASG) posted quarterly Other Working Capital Changes of $53000.0 for Q1 2026, down 92.52% year-over-year from $709000.0 in Q1 2025, and up 105.13% quarter-over-quarter from -$1.0 million in Q4 2025.
Passage BIO (PASG) Other Working Capital Changes (2024 - 2025) Analysis & Trends
Passage BIO's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $53000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 92.52% year-over-year to $53000.0; the TTM figure through Mar 2026 stood at -$884000.0 (down 38.99% YoY), while the FY2025 annual figure was -$228000.0, up 10.59% from the prior year.
- Other Working Capital Changes for Q3 2025 stood at $2.5 million, up from $1.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.1 million in Q1 2024, with the low at -$3.1 million in Q1 2023.
- The 5-year median for Other Working Capital Changes is -$359000.0 (2023), against an average of -$412000.0.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 1375.36% in 2022, then jumped 197.92% in 2025.
- Passage BIO's Other Working Capital Changes stood at $3.2 million in 2024, then fell by 22.5% to $2.5 million in 2025.
- Business Quant data shows PASG's Other Working Capital Changes at $2.5 million in Q3 2025, $1.0 million in Q2 2025, and $506000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Passage BIO | 13.99 Mn | 13.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 506,000.00 |
| Mar 31, 2025 | 506,000.00 |
| Mar 31, 2025 | 506,000.00 |
| Dec 31, 2024 | 3.23 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Dec 31, 2024 | 3.23 Mn |